Selection of tumor-binding ligands in cancer patients with phage display libraries.
about
Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopyCells and cell lysates: a direct approach for engineering antibodies against membrane proteins using yeast surface displayToward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challengesA review of current nanoparticle and targeting moieties for the delivery of cancer therapeuticsPhage display as a promising approach for vaccine developmentRapid preparation of mutated influenza hemagglutinins for influenza virus pandemic prevention.Serum anti-BPAG1 auto-antibody is a novel marker for human melanomaCombinatorial peptide libraries: mining for cell-binding peptides.Display technologies: application for the discovery of drug and gene delivery agents.Liposomes targeted by fusion phage proteinsPhage-display selection on tumor histological specimens with laser capture microdissection.Next-generation phage display: integrating and comparing available molecular tools to enable cost-effective high-throughput analysis.Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.Potential of phage-displayed peptide library technology to identify functional targeting peptidesCancer cell-specific internalizing ligands from phage displayed beta-lactamase-peptide fusion libraries.Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein.Construction and characterization of a novel fusion protein MG7-scFv/SEB against gastric cancer.Synthetic phage for tissue regenerationPhage display and molecular imaging: expanding fields of vision in living subjects.Self-assembly and mineralization of genetically modifiable biological nanofibers driven by β-structure formationBiopanning Phage-Display Libraries on Small Tissue Sections Captured by Laser Capture MicrodissectionPhage nanofibers induce vascularized osteogenesis in 3D printed bone scaffolds.Bacteriophage Bundles with Pre-Aligned Ca Initiate the Oriented Nucleation and Growth of Hydroxylapatite.Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubes.By-passing large screening experiments using sequencing as a tool to identify scFv fragments targeting atherosclerotic lesions in a novel in vivo phage display selection.A novel peptide (Thx) homing to non-small cell lung cancer identified by ex vivo phage display.Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodiesArchitectural insight into inovirus-associated vectors (IAVs) and development of IAV-based vaccines inducing humoral and cellular responses: implications in HIV-1 vaccinesControlled growth and differentiation of MSCs on grooved films assembled from monodisperse biological nanofibers with genetically tunable surface chemistries.Nanofibrous bio-inorganic hybrid structures formed through self-assembly and oriented mineralization of genetically engineered phage nanofibers.Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes.Carbon nanotubes as in vivo bacterial probesSelection strategies for anticancer antibody discovery: searching off the beaten path.Targeting glioblastoma via intranasal administration of Ff bacteriophages.Ligand-targeted theranostic nanomedicines against cancerAdvancement and applications of peptide phage display technology in biomedical scienceSelection of Novel Peptides Homing the 4T1 CELL Line: Exploring Alternative Targets for Triple Negative Breast Cancer.Novel nanoscale bacteriophage-based single-domain antibodies for the therapy of systemic infection caused by Candida albicans.Screening for a single-chain variable-fragment antibody that can effectively neutralize the cytotoxicity of the Vibrio parahaemolyticus thermolabile hemolysin.Oral Immunization of Rabbits with S. enterica Typhimurium Expressing Neisseria gonorrhoeae Filamentous Phage Φ6 Induces Bactericidal Antibodies Against N. gonorrhoeae.
P2860
Q24597813-4A6C1505-0B2B-4B7B-A4C7-0B582F0E1087Q26849777-44289756-1880-4E6D-947A-7CDC5E2BFA8DQ26995399-4D6B1D06-BA65-465F-A8A2-C43CD19DE4FBQ27006569-21CB8D02-8853-4EDD-BE7E-95F550DFAD7AQ28074592-2B837CB7-8CAF-461D-800C-C2150C555A84Q30383759-B20E39F0-DEBA-469A-9214-361E6C2FD8E1Q30982790-3843443F-894A-48B6-9A8C-CD3A3EC3FE26Q31144876-CB9AB13D-DE63-4A52-B77D-BA88CFC71AC3Q33264491-ED1258FA-F91C-464F-90A8-073F4D65A3D6Q33374206-A9534987-74A7-4B68-83C6-7E20D443553DQ33470770-001AFD42-63AF-4D26-A3ED-4E13F7E21D64Q33519545-0E7452C6-4B28-4A7B-B30B-D67822563AC0Q33520512-0204C84B-06B9-4A19-A801-F7A0C40895B4Q33530848-15AF22F6-7B8D-4856-8436-34379164BC35Q33539508-842227B0-BF50-48E5-B566-005057E0CEE5Q33596415-983EE82D-0E6C-4598-AC3E-D9B740BAF986Q33746766-FB808BFD-F630-4D39-BF73-0CCAD8A2D7DEQ33758770-24D31716-46AA-44B1-A0DF-6A8769547E3DQ33849788-4F58E3E6-56D7-43B7-AB06-EF87D1C40A22Q33882132-D7166BB8-9AE1-43B7-8235-A79416D2B5ADQ33984770-BC99D0B6-E5F1-4D62-B7F7-3D6BBBFC22C6Q34005796-C263CC85-BE96-4C0F-B4B0-692D4D107389Q34080723-44D9727B-EE92-44DF-963C-7CE7D53088EFQ34281226-E58ABF1A-9168-4E79-B88F-524FA9C9CB4BQ34353740-6A2E6ACD-9451-4FE1-8BDF-7DDD8C4D3999Q34473561-4C7E0CE1-7E58-4362-908F-CB8F93BED2E2Q34757809-ED06017F-8618-4CF9-B5B4-E88E72F86B83Q34774808-60CD1E13-06A4-4319-B144-AC7909367194Q34996387-F6F7C13C-D787-4259-9395-1397477CCB7FQ35008988-136265CB-AD94-482B-95EA-36EACA9F1FA6Q35024345-947F672A-1E7A-458E-8084-67FBC2208FF1Q35146707-FF88B84C-3233-46E8-8C36-5BC33C019A86Q35589427-4290A888-F02E-446D-A890-26D7E421709AQ35651275-E317146C-B1D4-43FD-BDE9-6C454F56AC64Q35895637-39B28D23-45DC-4747-8C9D-2ECAB49145A4Q35898339-AA1CBD1D-8C31-4E01-8C3D-D48ABBEE4CA1Q36109029-A5D2AE59-3B92-49B8-B6B5-81C8865C6D31Q36112280-17C706DA-524E-4605-8A14-DA4AE44076B9Q36155674-B4F07B90-8BF8-451E-ACEC-486205386EAEQ36650971-F39F2C0D-E1D1-427D-A656-9B07755288B3
P2860
Selection of tumor-binding ligands in cancer patients with phage display libraries.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Selection of tumor-binding ligands in cancer patients with phage display libraries.
@ast
Selection of tumor-binding ligands in cancer patients with phage display libraries.
@en
type
label
Selection of tumor-binding ligands in cancer patients with phage display libraries.
@ast
Selection of tumor-binding ligands in cancer patients with phage display libraries.
@en
prefLabel
Selection of tumor-binding ligands in cancer patients with phage display libraries.
@ast
Selection of tumor-binding ligands in cancer patients with phage display libraries.
@en
P2093
P1433
P1476
Selection of tumor-binding ligands in cancer patients with phage display libraries.
@en
P2093
Christian Thomas
David N Krag
Donald L Weaver
Girja S Shukla
Guang-Ping Shen
Stephanie Pero
Susan Burdette-Radoux
Susan Fuller
Taka Ashikaga
P304
P356
10.1158/0008-5472.CAN-05-4441
P407
P577
2006-08-01T00:00:00Z